Advanced Search

Technical Analysis for MCURF - Mind Cure Health Inc

Grade Last Price % Change Price Change
F 0.39 0.31% 0.0012
MCURF closed up 0.31 percent on Friday, March 5, 2021, on 57 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical MCURF trend table...
Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.31%
Stochastic Buy Signal Bullish 0.31%
Lizard Bullish Bullish Day Trade Setup 0.31%
Doji - Bullish? Reversal 0.31%
New 52 Week Low Weakness 0.31%
Wide Bands Range Expansion 0.31%
Older End-of-Day Signals for MCURF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Mind Cure Health Inc. engages in the development, manufacture, and distribution of a branded line of organic and functional mushroom powders. The company sells its products through online and retail stores in North America. Mind Cure Health Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.
Classification
Sector: Consumer Defensive
Industry: Packaged Foods
Keywords: E Health Retail Stores Mushroom

Is MCURF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Mar 4 MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury
Mar 3 MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research
Mar 2 MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada's First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin
Feb 22 Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors
Feb 18 MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on E-Commerce Platform
Feb 18 Mind Cure Comments on Recent Promotional Activity
Feb 17 Mind Cure Engages Dr. Dan Engle as Primary Investigator for Research in Traumatic Brain Injury with Psychedelics
Feb 16 MINDCURE's Proprietary Bioinformatics Platform, PsyCollage, Beta Tested and Deployed for Product Discovery and Lead Optimization
Feb 11 MINDCURE Announces Listing of Warrants
Feb 10 Mind Cure Announces Closing of $23 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option
See more MCURF news...

Indicators

Indicator Value
52 Week High 0.8584
52 Week Low 0.3462
Average Volume 399,035
200-Day Moving Average 0.0000
50-Day Moving Average 0.5192
20-Day Moving Average 0.4638
10-Day Moving Average 0.4227
Average True Range 0.0612
ADX 11.8
+DI 14.6184
-DI 22.4134
Chandelier Exit (Long, 3 ATRs ) 0.4327
Chandelier Exit (Short, 3 ATRs ) 0.5298
Upper Bollinger Band 0.5669
Lower Bollinger Band 0.3607
Percent B (%b) 0.14
BandWidth 44.4588
MACD Line -0.0370
MACD Signal Line -0.0304
MACD Histogram -0.0067
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.4694
Resistance 3 (R3) 0.4672 0.4386 0.4561
Resistance 2 (R2) 0.4386 0.4184 0.4397 0.4517
Resistance 1 (R1) 0.4143 0.4059 0.4000 0.4165 0.4473
Pivot Point 0.3857 0.3857 0.3786 0.3868 0.3857
Support 1 (S1) 0.3614 0.3655 0.3471 0.3636 0.3327
Support 2 (S2) 0.3328 0.3530 0.3339 0.3283
Support 3 (S3) 0.3085 0.3328 0.3239
Support 4 (S4) 0.3107